Wang, Bo
Iriguchi, Shoichi
Waseda, Masazumi
Ueda, Norihiro
Ueda, Tatsuki
Xu, Huaigeng http://orcid.org/0000-0002-4415-1287
Minagawa, Atsutaka
Ishikawa, Akihiro
Yano, Hisashi
Ishi, Tomoko
Ito, Ryoji http://orcid.org/0000-0003-2903-2332
Goto, Motohito http://orcid.org/0000-0001-6288-4583
Takahashi, Riichi
Uemura, Yasushi
Hotta, Akitsu
Kaneko, Shin http://orcid.org/0000-0003-2291-4586
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science
Japan Agency for Medical Research and Development
Article History
Received: 5 December 2019
Accepted: 13 April 2021
First Online: 17 May 2021
Competing interests
: S.K. is a founder, shareholder and chief scientific officer at Thyas Co. Ltd and received research funding from Takeda Pharmaceutical Co. Ltd, Kirin Co. Ltd, Terumo Co. Ltd, Tosoh Co. Ltd and Thyas Co. Ltd.